HomeCompareEPR vs HOLX

EPR vs HOLX: Dividend Comparison 2026

EPR yields 7.18% · HOLX yields 2.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPR wins by $69.92M in total portfolio value
10 years
EPR
EPR
● Live price
7.18%
Share price
$49.29
Annual div
$3.54
5Y div CAGR
68.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69.95M
Annual income
$60,903,643.89
Full EPR calculator →
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →

Portfolio growth — EPR vs HOLX

📍 EPR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEPRHOLX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EPR + HOLX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EPR pays
HOLX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPR
Annual income on $10K today (after 15% tax)
$610.47/yr
After 10yr DRIP, annual income (after tax)
$51,768,097.31/yr
HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
At 15% tax rate, EPR beats the other by $51,767,830.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPR + HOLX for your $10,000?

EPR: 50%HOLX: 50%
100% HOLX50/50100% EPR
Portfolio after 10yr
$34.98M
Annual income
$30,451,978.95/yr
Blended yield
87.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HOLX right now

EPR
Analyst Ratings
5
Buy
14
Hold
2
Sell
Consensus: Hold
Price Target
$59.50
+20.7% upside vs current
Range: $54.00 — $65.50
Altman Z
0.8
Piotroski
6/9
HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPR buys
0
HOLX buys
0
No recent congressional trades found for EPR or HOLX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEPRHOLX
Forward yield7.18%2.65%
Annual dividend / share$3.54$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR68.5%0%
Portfolio after 10y$69.95M$23.6K
Annual income after 10y$60,903,643.89$314.03
Total dividends collected$69.19M$2.9K
Payment frequencyquarterlyquarterly
SectorREITHealthcare
Analyst consensusHoldHold
Analyst price target$59.50$77.80

Year-by-year: EPR vs HOLX ($10,000, DRIP)

YearEPR PortfolioEPR Income/yrHOLX PortfolioHOLX Income/yrGap
1← crossover$11,910$1,210.16$10,965$264.73+$945.00EPR
2$15,014$2,269.75$12,004$271.27+$3.0KEPR
3$20,570$4,505.70$13,121$277.55+$7.4KEPR
4$31,732$9,721.49$14,323$283.54+$17.4KEPR
5$57,569$23,615.77$15,615$289.27+$42.0KEPR
6$129,069$67,470.08$17,003$294.73+$112.1KEPR
7$376,314$238,210.90$18,493$299.93+$357.8KEPR
8$1,496,381$1,093,724.46$20,093$304.87+$1.48MEPR
9$8,449,943$6,848,815.64$21,809$309.57+$8.43MEPR
10$69,945,083$60,903,643.89$23,649$314.03+$69.92MEPR

EPR vs HOLX: Complete Analysis 2026

EPRREIT

EPR Properties is a leading experiential net lease real estate investment trust (REIT), specializing in select enduring experiential properties in the real estate industry. We focus on real estate venues which create value by facilitating out of home leisure and recreation experiences where consumers choose to spend their discretionary time and money. We have nearly $6.7 billion in total investments across 44 states. We adhere to rigorous underwriting and investing criteria centered on key industry, property and tenant level cash flow standards. We believe our focused approach provides a competitive advantage and the potential for stable and attractive returns.

Full EPR Calculator →

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →
📬

Get this EPR vs HOLX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPR vs SCHDEPR vs JEPIEPR vs OEPR vs KOEPR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.